DEA to Publish Final Rule Rescheduling Hydrocodone Combination Products
On Friday the U. S. Drug Enforcement Administration (DEA) will publish in the Federal Register the Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II, as recommended by the Assistant Secretary for Health of the U.S. Department of Health and Human Services (HHS) and as supported by the DEA’s own evaluation of relevant data. The Federal Register has made the Final Rule available for preview on its website today at http://go.usa.gov/mc8d.
|JUL 02||DEA and US Attorney Announce Charges against Three Leaders of Peruvian Terrorist Organization Shining Path|
|JUL 02||Seven Colombian Nationals Charged in Connection with the Murder of a DEA Agent Extradited to the United States|
|MAY 28||International Scheme to Extort Americans by Impersonating DEA Special Agents Foiled|
|MAY 08||DEA’S National Prescription Drug Take-Back Days Meet a Growing Need for Americans|
|MAY 07||DEA News: Huge Synthetic Drug Takedown|